A61K 38/36
Blood coagulation or fibrinolysis factors
A61K38/36 (Blood coagulation or fibrinolysis factors) appears on 943 US grants and 1,643 published applications in this corpus.
Search patents in A61K- Granted patents
- 943
- Published applications
- 1,643
- Assignees
- 625
- Inventors
- 2,308
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 1 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 6 | 0 |
| 1985 | 2 | 0 |
| 1986 | 2 | 0 |
| 1987 | 3 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 2 | 0 |
| 1991 | 1 | 0 |
| 1992 | 4 | 0 |
| 1993 | 4 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 5 | 0 |
| 1997 | 13 | 0 |
| 1998 | 15 | 0 |
| 1999 | 16 | 0 |
| 2000 | 9 | 0 |
| 2001 | 12 | 7 |
| 2002 | 8 | 23 |
| 2003 | 12 | 30 |
| 2004 | 11 | 40 |
| 2005 | 9 | 50 |
| 2006 | 14 | 52 |
| 2007 | 24 | 57 |
| 2008 | 18 | 47 |
| 2009 | 19 | 64 |
| 2010 | 27 | 62 |
| 2011 | 38 | 67 |
| 2012 | 33 | 66 |
| 2013 | 47 | 71 |
| 2014 | 49 | 84 |
| 2015 | 53 | 108 |
| 2016 | 49 | 108 |
| 2017 | 49 | 84 |
| 2018 | 46 | 76 |
| 2019 | 54 | 86 |
| 2020 | 51 | 87 |
| 2021 | 52 | 73 |
| 2022 | 46 | 65 |
| 2023 | 35 | 72 |
| 2024 | 34 | 64 |
| 2025 | 33 | 53 |
| 2026 | 26 | 47 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Method for manufacturing mitochondria-rich plasma22 Sep 2026US 12,741,068 B2Taiwan Mitochondrion Applied Technology Co., Ltd.
- Methods and compositions for treating cancer with von Willebrand factor peptide linked to immunotherapeutic antibodies11 Aug 2026US 12,706,227 B2The University of Chicago
- Composition for kidney treatment using omentum, a medical kit for kidney treatment, including the same, and film for kidney treatment, including cured product thereof21 Jul 2026US 12,685,752 B2Rokit Healthcare Inc.
- Extracellular vesicles and compositions thereof14 Jul 2026US 12,678,465 B2Exo Biologics SA
- Lyophilized recombinant VWF formulations16 Jun 2026US 12,653,867 B2Takeda Pharmaceutical Company Limited
- Extracellular Vesicles and Compositions Thereof1 Oct 2026US 2026/0294977 A1Exo Biologics SA
- Use of mimetic peptide containing fibrinogen rgd motif in preparation of medications for preventing and/or treating parkinson's disease1 Oct 2026US 2026/0295017 A1Zhujiang Hospital, Southern Medical University
- Systems and methods to provide therapeutic factor viii using ultrasound-mediated nucleic acid delivery1 Oct 2026US 2026/0295083 A1Seattle Children's Hospital d/b/a Seattle Children's Research Institute
- Liver-specific regulatory nucleic acid sequences1 Oct 2026US 2026/0297615 A1Askbio Inc.
- Lentiviral System17 Sep 2026US 2026/0275376 A1Expression Therapeutics LLC
Most cited
By later US patents
- Supplemented and unsupplemented tissue sealants, methods of their production and use441US 6,197,325 B1American National Red Cross · 2001
- Prolonged release microcapsule and its production372US 4,652,441 ATakeda Chemical Industries, Ltd. · 1987
- Medical implants and fibrosis-inducing agents330US 7,166,570 B2Angiotech International AG · 2007
- Supplemented and unsupplemented tissue sealants, methods of their production and use292US 6,054,122 AAmerican National Red Cross · 2000
- Chitin hydrogels, methods of their production and use245US 6,124,273 AAmerican National Red Cross · 2000